Tomasz Rusak

Dr. Tomasz Rusak

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
Myroslav SprynskyyMyroslav Sprynskyy
Myroslav Sprynskyy
BBBogusław Buszewski
Bogusław Buszewski
Artur TerzykArtur Terzyk
Artur Terzyk
JNJacek Namiesnik
Jacek Namiesnik

1 February 2001 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Closed access
Artur TerzykArtur Terzyk
Artur Terzyk

1 December 2003 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
Artur TerzykArtur Terzyk
Artur Terzyk

1 March 2008 in Advances in Colloid and Interface Science
Verified
Journal Article
Closed access
SFSylwester Furmaniak
Sylwester Furmaniak
PGPiotr Antoni Gauden
Piotr Antoni Gauden
Artur TerzykArtur Terzyk
Artur Terzyk
GRGerhard Rychlicki
Gerhard Rychlicki

1 April 2005 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
Myroslav SprynskyyMyroslav Sprynskyy
Myroslav Sprynskyy
MLMariya Lebedynets
Mariya Lebedynets
Artur TerzykArtur Terzyk
Artur Terzyk
PKPiotr Kowalczyk
Piotr Kowalczyk
JNJacek Namiesnik
Jacek Namiesnik
BBBogusław Buszewski
Bogusław Buszewski

1 January 2015 in Advances in Condensed Matter Physics
Verified
Journal Article
Open access
PDF file
KWKarolina Werengowska-Ciećwierz
Karolina Werengowska-Ciećwierz
Marek WiśniewskiMarek Wiśniewski
Marek Wiśniewski
Artur TerzykArtur Terzyk
Artur Terzyk
SFSylwester Furmaniak
Sylwester Furmaniak
Nanomedicine is, generally, the application of nanotechnology to medicine. The term nanomedicine includes monitoring, construction of novel drug delivery systems, and any possible future applications of nanotechnology and nanovaccinology. In this review, the most important ligand-nanocarrier and drug-nanocarrier bioconjugations are described. The detailed characterizations of covalently formed bonds between targeted ligand and nanocarrier, including amide, thioether, disulfide, acetyl-hydrazone and polycyclic groups, are described. Also, the coupling of small elements and heteroatoms in the form of R-X-R the “click chemistry” groups is shown. Physical adsorption and chemical bonding of drug to nanocarrier surface involving drug on the internal or external surfaces of nanocarriers are described throughout possibility of the formation of the above-mentioned functionalities. Moreover, the most popular nanostructures (liposomes, micelles, polymeric nanoparticles, dendrimers, carbon nanotubes, and nanohorns) are characterized as nanocarriers. Building of modern drug carrier is a new method which could be effectively applied in targeted anticancer therapy.